GlassScriptPhysician profile
Logan M Bushnell
NPI 1659878437
$12,481.61
in general payments reported to CMS, 2019-2025
19 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.77 · 2020: $63.45 · 2021: $160 · 2022: $2,928 · 2023: $5,889 · 2024: $2,906 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,703 · Food and Beverage: $4,033 · Education: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,703.43 |
| Food and Beverage | $4,032.78 |
| Education | $499.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,455.70 | 2022-2025 | Mako, Pro, Gamma |
| Zimmer Biomet Holdings, INC. | $3,011.60 | 2023-2025 | Persona, Affixus, Rosa |
| Cdc Medical LLC | $1,350.61 | 2022-2024 | |
| Arthrex, INC. | $1,101.23 | 2022 | |
| Si-Bone, INC. | $565.68 | 2021-2024 | |
| Invictus Surgical Incorporated | $149.09 | 2024 | |
| Alphatec Spine, INC | $142.46 | 2025 | |
| Kerecis Limited | $126.44 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Cerapedics INC. | $105.60 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Davol INC. | $85.50 | 2025 | Arista |
| Kci USA, INC. | $84.92 | 2022 | |
| Mallinckrodt Enterprises LLC | $66.99 | 2019 | |
| Mallinckrodt Hospital Products INC. | $63.45 | 2020 | |
| Illuminoss Medical, INC. | $49.44 | 2024 | |
| Skeletal Dynamics INC | $30.52 | 2025 | Ijs, Geminus, Implate |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $26.78 | 2019 | |
| Avanos Medical | $24.04 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $22.78 | 2021 | |
| Endo Pharmaceuticals INC. | $18.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Bushnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.